Cargando…
Role of Sodium-Glucose Co-Transporter 2 Inhibitors in Chronic Kidney Disease, Congestive Heart Failure and Stroke—A Review and Clinical Guide for Healthcare Professionals
Diabetic kidney disease (DKD) causes a progressive decline in renal function, leading to end-stage kidney disease (ESKD), and increases the likelihood of cardiovascular events and mortality. The recent introduction of the sodium-glucose co-transporter 2 (SGLT-2) inhibitor has been a game changer in...
Autores principales: | Singh, Prabhat, Goyal, Lokesh, Mallick, Deobrat C., Surani, Salim R., Yashi, Kanica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574010/ https://www.ncbi.nlm.nih.gov/pubmed/37834846 http://dx.doi.org/10.3390/jcm12196202 |
Ejemplares similares
-
Tizanidine Toxicity From Ciprofloxacin: A Cautionary Tale
por: Goyal, Lokesh, et al.
Publicado: (2022) -
COVID-19 Induced Postural Orthostatic Tachycardia Syndrome (POTS): A Review
por: Mallick, Deobrat, et al.
Publicado: (2023) -
Severe Case of Cholestatic Hepatitis From Amoxicillin/Clavulanic Acid
por: Goyal, Lokesh, et al.
Publicado: (2022) -
Systemic Venous Congestion Reviewed
por: Banjade, Prakash, et al.
Publicado: (2023) -
Type 1 Pulmonary Hypertension and Silicosis in a Bluestone Cutter: A Case Report on Raising Awareness
por: Luhadia, Kunjal, et al.
Publicado: (2023)